• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

胆管受累预示着胆囊癌切除术后预后不良。

Bile duct involvement portends poor prognosis in resected gallbladder carcinoma.

作者信息

Eil Robert, Hansen Paul D, Cassera Maria, Orloff Susan L, Sheppard Brett C, Diggs Brian, Billingsley Kevin G

机构信息

Division of Surgical Oncology Oregon Health and Sciences University Portland, OR.

出版信息

Gastrointest Cancer Res. 2013 Jul;6(4):101-5.

PMID:24147157
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3782874/
Abstract

BACKGROUND

Gallbladder cancer (GBC) carries an unfavorable prognosis with high mortality. This retrospective study was conducted to identify prognostic factors after resection of GBC, to assist in selecting appropriate surgical and adjuvant therapy.

METHODS

Sixty-two patients from two institutions were identified with GBC by pathology. In 25, the cancer was unresectable at presentation. The remaining 37 patients comprised the study population. Log-rank analysis was used to assess univariate association with disease-free survival (DFS) and disease-specific survival (DSS). Cox regression was used for multivariate analysis.

RESULTS

Median DFS and DSS were 22.6 and 28.5 months respectively, with a median follow-up of 44.2 months. On univariate analysis, bile duct (BD) involvement was significantly associated with decreased DFS (P ≤ .001) and DSS (P = .004). BD involvement was uniformly fatal. LN involvement was not significantly associated with DFS or DSS (P = .85, P = .54).

CONCLUSIONS

All patients with BD involvement in our population died of the disease. The subset of patients with resectable GBC and BD involvement is a group that is at high risk for recurrence and should be treated as such. In our small population, preoperative and intraoperative methods evaluating BD involvement were unreliable.

摘要

背景

胆囊癌(GBC)预后不佳,死亡率高。本回顾性研究旨在确定GBC切除术后的预后因素,以协助选择合适的手术和辅助治疗。

方法

通过病理学鉴定来自两家机构的62例GBC患者。其中25例患者就诊时癌症无法切除。其余37例患者构成研究人群。采用对数秩分析评估与无病生存期(DFS)和疾病特异性生存期(DSS)的单变量关联。采用Cox回归进行多变量分析。

结果

DFS和DSS的中位数分别为22.6个月和28.5个月,中位随访时间为44.2个月。单变量分析显示,胆管(BD)受累与DFS降低(P≤0.001)和DSS降低(P = 0.004)显著相关。BD受累均导致死亡。淋巴结(LN)受累与DFS或DSS无显著关联(P = 0.85,P = 0.54)。

结论

我们研究人群中所有BD受累的患者均死于该疾病。可切除的GBC且BD受累的患者亚组是复发高危人群,应按此进行治疗。在我们的小样本研究中,评估BD受累的术前和术中方法不可靠。

相似文献

1
Bile duct involvement portends poor prognosis in resected gallbladder carcinoma.胆管受累预示着胆囊癌切除术后预后不良。
Gastrointest Cancer Res. 2013 Jul;6(4):101-5.
2
Effects of Cystic Duct Margin Involvement on the Survival Rates of Patients With Gallbladder Cancer: A Propensity Score-Matched Case-Control Study.胆囊管切缘受累对胆囊癌患者生存率的影响:一项倾向评分匹配的病例对照研究。
Cureus. 2023 Dec 15;15(12):e50585. doi: 10.7759/cureus.50585. eCollection 2023 Dec.
3
Aggressive Surgical Approach for Gallbladder Cancer: a Single-Center Experience from Northern India.胆囊癌的积极手术治疗方法:来自印度北部的单中心经验。
J Gastrointest Cancer. 2015 Dec;46(4):399-407. doi: 10.1007/s12029-015-9766-4.
4
Extra-Hepatic Bile Duct Resection: an Insight in the Management of Gallbladder Cancer.肝外胆管切除术:胆囊癌治疗的见解
J Gastrointest Cancer. 2015 Sep;46(3):291-6. doi: 10.1007/s12029-015-9737-9.
5
The role of surgery and adjuvant therapy in lymph node-positive cancers of the gallbladder and intrahepatic bile ducts.手术及辅助治疗在胆囊和肝内胆管淋巴结阳性癌症中的作用。
Cancer. 2018 Jan 1;124(1):74-83. doi: 10.1002/cncr.30968. Epub 2017 Aug 25.
6
Analysis of the relationships between clinicopathologic factors and survival in gallbladder cancer following surgical resection with curative intent.分析胆囊癌根治性切除术后临床病理因素与生存的关系。
PLoS One. 2012;7(12):e51513. doi: 10.1371/journal.pone.0051513. Epub 2012 Dec 31.
7
Impact of Adjuvant Therapy on Survival in Curatively Resected Gallbladder Carcinoma.辅助治疗对胆囊癌根治性切除术后生存率的影响
J Clin Diagn Res. 2015 Sep;9(9):XC01-XC04. doi: 10.7860/JCDR/2015/15113.6436. Epub 2015 Sep 1.
8
Managing the incidentally detected gallbladder cancer: algorithms and controversies.偶然发现的胆囊癌的处理:算法和争议。
Int J Surg. 2014;12 Suppl 2:S108-S119. doi: 10.1016/j.ijsu.2014.08.367. Epub 2014 Aug 23.
9
Adjuvant Transarterial chemoembolization does not influence recurrence-free or overall survival in patients with combined hepatocellular carcinoma and Cholangiocarcinoma after curative resection: a propensity score matching analysis.辅助经动脉化疗栓塞治疗对根治性切除术后合并肝细胞癌和胆管细胞癌患者的无复发生存和总体生存无影响:倾向评分匹配分析。
BMC Cancer. 2020 Jul 10;20(1):642. doi: 10.1186/s12885-020-07138-z.
10
Is postoperative adjuvant chemotherapy useful for gallbladder carcinoma? A phase III multicenter prospective randomized controlled trial in patients with resected pancreaticobiliary carcinoma.术后辅助化疗对胆囊癌是否有用?一项针对已切除胰胆管癌患者的III期多中心前瞻性随机对照试验。
Cancer. 2002 Oct 15;95(8):1685-95. doi: 10.1002/cncr.10831.

引用本文的文献

1
Imaging patterns of wall thickening type of gallbladder cancer.胆囊癌壁增厚型的影像学表现
Clin Exp Hepatol. 2022 Dec;8(4):255-266. doi: 10.5114/ceh.2022.122285. Epub 2022 Dec 28.
2
Assessment of tumor markers CA 19-9, CEA, CA 125, and CA 242 for the early diagnosis and prognosis prediction of gallbladder cancer.评估肿瘤标志物CA 19 - 9、癌胚抗原(CEA)、CA 125和CA 242在胆囊癌早期诊断及预后预测中的作用。
World J Gastrointest Surg. 2022 Nov 27;14(11):1272-1284. doi: 10.4240/wjgs.v14.i11.1272.
3
A Gallbladder Cancer Survival Prediction Model Based on Multimodal Fusion Analysis.基于多模态融合分析的胆囊癌生存预测模型。
Dig Dis Sci. 2023 May;68(5):1762-1776. doi: 10.1007/s10620-022-07782-4. Epub 2022 Dec 11.
4
Survival Prediction in Gallbladder Cancer Using CT Based Machine Learning.基于CT的机器学习在胆囊癌生存预测中的应用
Front Oncol. 2020 Nov 27;10:604288. doi: 10.3389/fonc.2020.604288. eCollection 2020.
5
Surgical treatment of gallbladder carcinoma: a critical review.胆囊癌的外科治疗:一项批判性综述。
Updates Surg. 2015 Dec;67(4):339-51. doi: 10.1007/s13304-015-0328-x. Epub 2015 Nov 12.
6
Extra-Hepatic Bile Duct Resection: an Insight in the Management of Gallbladder Cancer.肝外胆管切除术:胆囊癌治疗的见解
J Gastrointest Cancer. 2015 Sep;46(3):291-6. doi: 10.1007/s12029-015-9737-9.
7
Combined detection tumor markers for diagnosis and prognosis of gallbladder cancer.联合检测肿瘤标志物用于胆囊癌的诊断和预后评估。
World J Gastroenterol. 2014 Apr 14;20(14):4085-92. doi: 10.3748/wjg.v20.i14.4085.

本文引用的文献

1
Nomogram for predicting the benefit of adjuvant chemoradiotherapy for resected gallbladder cancer.预测可切除胆囊癌辅助放化疗获益的列线图。
J Clin Oncol. 2011 Dec 10;29(35):4627-32. doi: 10.1200/JCO.2010.33.8020. Epub 2011 Nov 7.
2
Gallbladder cancer: differences in presentation, surgical treatment, and survival in patients treated at centers in three countries.胆囊癌:在三个国家的中心接受治疗的患者在表现、手术治疗和生存方面的差异。
J Am Coll Surg. 2011 Jan;212(1):50-61. doi: 10.1016/j.jamcollsurg.2010.09.009. Epub 2010 Nov 12.
3
Analysis of the extent of resection for adenocarcinoma of the gallbladder.胆囊腺癌切除范围分析。
Ann Surg Oncol. 2009 Apr;16(4):806-16. doi: 10.1245/s10434-008-0189-3. Epub 2008 Nov 5.
4
Gallbladder cancer (GBC): 10-year experience at Memorial Sloan-Kettering Cancer Centre (MSKCC).胆囊癌(GBC):纪念斯隆凯特琳癌症中心(MSKCC)的10年经验。
J Surg Oncol. 2008 Dec 1;98(7):485-9. doi: 10.1002/jso.21141.
5
Prediction model for estimating the survival benefit of adjuvant radiotherapy for gallbladder cancer.评估胆囊癌辅助放疗生存获益的预测模型
J Clin Oncol. 2008 May 1;26(13):2112-7. doi: 10.1200/JCO.2007.14.7934. Epub 2008 Mar 31.
6
Gallbladder cancer: Defining the indications for primary radical resection and radical re-resection.胆囊癌:明确原发性根治性切除术和根治性再次切除术的适应证。
Ann Surg Oncol. 2007 Feb;14(2):833-40. doi: 10.1245/s10434-006-9097-6. Epub 2006 Nov 11.
7
Incidental gallbladder cancer diagnosed during and after laparoscopic cholecystectomy.腹腔镜胆囊切除术期间及术后诊断出的意外胆囊癌。
J Nippon Med Sch. 2006 Jun;73(3):136-40. doi: 10.1272/jnms.73.136.
8
Cancer statistics, 2006.2006年癌症统计数据。
CA Cancer J Clin. 2006 Mar-Apr;56(2):106-30. doi: 10.3322/canjclin.56.2.106.
9
Gallbladder cancer: comparison of patients presenting initially for definitive operation with those presenting after prior noncurative intervention.胆囊癌:初次接受根治性手术的患者与先前接受非根治性干预后就诊的患者的比较。
Ann Surg. 2000 Oct;232(4):557-69. doi: 10.1097/00000658-200010000-00011.
10
Liver, gallbladder, extrahepatic bile ducts, and pancreas.肝脏、胆囊、肝外胆管和胰腺。
Cancer. 1995 Jan 1;75(1 Suppl):171-90. doi: 10.1002/1097-0142(19950101)75:1+<171::aid-cncr2820751306>3.0.co;2-2.